4//SEC Filing
DUNAYEVICH EDUARDO 4
Accession 0001181431-09-052658
CIK 0001382911other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 6:47 PM ET
Size
12.0 KB
Accession
0001181431-09-052658
Insider Transaction Report
Form 4
DUNAYEVICH EDUARDO
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2009-11-16$2.00/sh+75,000$150,000→ 75,000 total - Exercise/Conversion
Stock Option (right to buy)
2009-11-16−75,000→ 156,741 totalExercise: $2.00Exp: 2016-09-27→ Common Stock (75,000 underlying) - Sale
Common Stock
2009-11-16$7.50/sh−75,000$562,500→ 0 total
Footnotes (3)
- [F1]This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 09/09/2009.
- [F2]25% of the original grant vested on 8/8/2007. The remaining shares vest 1/36 per month until 8/8/2010.
- [F3]Not applicable to this transaction.
Issuer
Orexigen Therapeutics, Inc.
CIK 0001382911
Entity typeother
Related Parties
1- filerCIK 0001396783
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 6:47 PM ET
- Size
- 12.0 KB